Rose Pharma
2 known investors
Find your way into Rose Pharma
367 people in our graph share verified history with the Rose Pharma team — schools, employers, funds. One of them is your warm intro.
Rebecca Jamesunlockedknows Lynn Sullivan · together at The Wharton School (overlapped)
×10knows the team · via The Wharton School
knows the team · via Novo Nordisk
Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders. Led by experienced executives from major pharmaceutical firms, the company operates in the medtech/biotech sectors.
Founders & leadership
EK
Enda KennyinCEO
LS
Lynn SullivaninChief Business OfficerLynn Sullivan is Chief Business Officer at Rose Pharma, a pharmaceutical company developing gastroenterology and metabolic disorder therapies. She brings over 20 years of commercial and operational experience in the bio/pharmaceutical sector, having led global commercial teams across the U.S., Europe, Middle East, Africa, and Russia, with product launch and P&L management expertise.
Investors · 2
In the news
MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching | Asianet Newsablenewsable.asianetnews.com · Sep 2026Frequently asked questions
- What does Rose Pharma do?
- Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders. Led by experienced executives from major pharmaceutical firms, the company operates in the medtech/biotech sectors.
- Who are Rose Pharma's investors?
- Rose Pharma's investors include Scientia Ventures, Rosetta Capital Ltd..